"Transcription physiology" of pigment formation in melanocytes: Central role of MITF

Experimental Dermatology

Volumn 19, Issue 7, 2010, Pages 617-627

  Vachtenheim, Jiri ^a   Borovanský, Jan ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Melanin; Melanoma; Microphthalmia; Microphthalmia associated transcription factor; Pigmentation

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA CATENIN; BETA ENDORPHIN; CORTICOTROPIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; DOPACHROME; EUMELANIN; GLYCOPROTEIN; GUANOSINE TRIPHOSPHATASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERMEDIN; LYMPHOID ENHANCER FACTOR 1; MELANIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; PROOPIOMELANOCORTIN; PROTEIN P53; QUINONE DERIVATIVE; RAB27A PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TUMOR SUPPRESSOR PROTEIN; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2; UNINDEXED DRUG;

ACETYLATION; ALBINISM; BIOSYNTHESIS; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; EYE COLOR; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSCRIPTION; HAIR COLOR; HUMAN; KERATINOCYTE; MELANOCYTE; MELANOGENESIS; MELANOMA; MELANOSOME; NONHUMAN; OCULAR ALBINISM; PIGMENT CELL; PIGMENTATION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TRANSCRIPTION REGULATION; ULTRAVIOLET IRRADIATION; ULTRAVIOLET RADIATION;

ANIMALS; BASE SEQUENCE; HUMANS; MELANINS; MELANOCYTES; MELANOMA; MELANOSOMES; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MODELS, BIOLOGICAL; PROMOTER REGIONS, GENETIC; SKIN PIGMENTATION; STRESS, PHYSIOLOGICAL; TRANS-ACTIVATORS;

EID: 77954649705     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.01053.x     Document Type: Review

References (133)

1. Prota G, D'Ischia M, Napolitano A. The chemistry of melanins and related metabolites. The Pigmentary System: Physiology and Pathophysiology 1998, 307-333. Nordlund J J, Boissy R E, Hearing V JKing R AOrtonne J P. In, eds, New York and Oxford, Oxford University Press
2. Raper H S. The Tyrosinase-tyrosine Reaction: production from Tyrosine of 5: 6-Dihydroxyindole and 5: 6-Dihydroxyindole-2-carboxylic Acid-the Precursors of Melanin. Biochem J 1927, 21:89-96.
3. Hodgkinson C A, Moore K J, Nakayama A. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 1993, 74:395-404.
4. Hughes M J, Lingrel J B, Krakowsky J M, Anderson K P. A helix-loop-helix transcription factor-like gene is located at the mi locus. J Biol Chem 1993, 268:20687-20690.
5. Moore K J. Insight into the microphthalmia gene. Trends Genet 1995, 11:442-448.
6. Steingrimsson E, Moore K J, Lamoreux M L. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet 1994, 8:256-263.
7. Steingrimsson E, Copeland N G, Jenkins N A. Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 2004, 38:365-411.
8. Tassabehji M, Newton V E, Read A P. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 1994, 8:251-255.
9. Carreira S, Goodall J, Aksan I. Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 2005, 433:764-769.
10. Loercher A E, Tank E M, Delston R B, Harbour J W. MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J Cell Biol 2005, 168:35-40.
11. Du J, Widlund H R, Horstmann M A. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell 2004, 6:565-576.
12. McGill G G, Horstmann M, Widlund H R. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002, 109:707-718.
13. Dynek J N, Chan S M, Liu J, Zha J, Fairbrother W J, Vucic D. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. Cancer Res 2008, 68:3124-3132.
14. Carreira S, Goodall J, Denat L. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 2006, 20:3426-3439.
15. Busca R, Berra E, Gaggioli C. Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. J Cell Biol 2005, 170:49-59.
16. McGill G G, Haq R, Nishimura E K, Fisher D E. c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem 2006, 281:10365-10373.
17. Carreira S, Liu B, Goding C R. The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes. J Biol Chem 2000, 275:21920-21927.
18. Sanchez-Martin M, Rodriguez-Garcia A, Perez-Losada J, Sagrera A, Read A P, Sanchez-Garcia I. SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum Mol Genet 2002, 11:3231-3236.
19. Liu F, Fu Y, Meyskens F L. MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. J Invest Dermatol 2009, 129:422-431.
20. Hoek K S, Schlegel N C, Eichhoff O M. Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res 2008, 21:665-676.
21. Opdecamp K, Nakayama A, Nguyen M T, Hodgkinson C A, Pavan W J, Arnheiter H. Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. Development 1997, 124:2377-2386.
22. Levy C, Khaled M, Fisher D E. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 2006, 12:406-414.
23. Garraway L A, Widlund H R, Rubin M A. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005, 436:117-122.
24. Beuret L, Flori E, Denoyelle C. Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis. J Biol Chem 2007, 282:14140-14147.
25. Vance K W, Carreira S, Brosch G, Goding C R. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res 2005, 65:2260-2268.
26. Tachibana M, Perez-Jurado L A, Nakayama A. Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3. Hum Mol Genet 1994, 3:553-557.
27. Denat L, Larue L. Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor. Bull Cancer (In French) 2007, 94:81-92.
28. Hou L, Pavan W J. Transcriptional and signaling regulation in neural crest stem cell-derived melanocyte development: do all roads lead to Mitf? Cell Res 2008, 18:1163-1176.
29. Sato S, Roberts K, Gambino G, Cook A, Kouzarides T, Goding C R. CBP/p300 as a co-factor for the Microphthalmia transcription factor. Oncogene 1997, 14:3083-3092.
30. Vachtenheim J, Drdova B. A dominant negative mutant of microphthalmia transcription factor (MITF) lacking two transactivation domains suppresses transcription mediated by wild type MITF and a hyperactive MITF derivative. Pigment Cell Res 2004, 17:43-50.
31. Aksan I, Goding C R. Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo. Mol Cell Biol 1998, 18:6930-6938.
32. Hemesath T J, Steingrimsson E, McGill G. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 1994, 8:2770-2780.
33. Goding C R. Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 2000, 14:1712-1728.
34. Goding C, Meyskens F L. Microphthalmic-associated transcription factor integrates melanocyte biology and melanoma progression. Clin Cancer Res 2006, 12:1069-1073.
35. Slominski A, Tobin D J, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004, 84:1155-1228.
36. Jacquemin P, Lannoy V J, O'Sullivan J, Read A, Lemaigre F P, Rousseau G G. The transcription factor onecut-2 controls the microphthalmia-associated transcription factor gene. Biochem Biophys Res Commun 2001, 285:1200-1205.
37. Grabacka M, Placha W, Urbanska K, Laidler P, Plonka P M, Reiss K. PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91. Pigment Cell Melanoma Res 2008, 21:388-396.
38. Schallreuter K U, Kothari S, Chavan B, Spencer J D. Regulation of melanogenesis--controversies and new concepts. Exp Dermatol 2008, 17:395-404.
39. von Strandmann E P, Senkel S, Ryffel G, Hengge U R. Dimerization co-factor of hepatocyte nuclear factor 1/pterin-4alpha-carbinolamine dehydratase is necessary for pigmentation in Xenopus and overexpressed in primary human melanoma lesions. Am J Pathol 2001, 158:2021-2029.
40. Goodall J, Carreira S, Denat L. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells. Cancer Res 2008, 68:7788-7794.
41. Wu M, Hemesath T J, Takemoto C M. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 2000, 14:301-312.
42. Xu W, Gong L, Haddad M M. Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res 2000, 255:135-143.
43. Price E R, Ding H F, Badalian T. Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia. J Biol Chem 1998, 273:17983-17986.
44. Vachtenheim J, Sestakova B, Tuhackova Z. Inhibition of MITF transcriptional activity independent of targeting p300/CBP coactivators. Pigment Cell Res 2007, 20:41-51.
45. Takeda K, Takemoto C, Kobayashi I. Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Hum Mol Genet 2000, 9:125-132.
46. Miller A J, Levy C, Davis I J, Razin E, Fisher D E. Sumoylation of MITF and its related family members TFE3 and TFEB. J Biol Chem 2005, 280:146-155.
47. Murakami H, Arnheiter H. Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. Pigment Cell Res 2005, 18:265-277.
48. Riley P A. The great DOPA mystery: the source and significance of DOPA in phase I melanogenesis. Cell Mol Biol (Noisy -le-grand) 1999, 45:951-960.
49. Simon J D, Hong L, Peles D N. Insights into melanosomes and melanin from some interesting spatial and temporal properties. J Phys Chem B 2008, 112:13201-13217.
50. Tsukamoto K, Jackson I J, Urabe K, Montague P M, Hearing V J. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 1992, 11:519-526.
51. Kobayashi T, Urabe K, Winder A. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 1994, 13:5818-5825.
52. Korner A, Pawelek J. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 1982, 217:1163-1165.
53. Borovansky J, Mirejovsky P, Riley P A. Possible relationship between abnormal melanosome structure and cytotoxic phenomena in malignant melanoma. Neoplasma 1991, 38:393-400.
54. Pawelek J M, Lerner A B. 5,6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature 1978, 276:626-628.
55. Riley P A. Melanogenesis and melanoma. Pigment Cell Res 2003, 16:548-552.
56. Bentley N J, Eisen T, Goding C R. Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol 1994, 14:7996-8006.
57. Yasumoto K, Yokoyama K, Shibata K, Tomita Y, Shibahara S. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol Cell Biol 1994, 14:8058-8070.
58. Bertolotto C, Busca R, Abbe P. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol 1998, 18:694-702.
59. Yasumoto K, Yokoyama K, Takahashi K, Tomita Y, Shibahara S. Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes. J Biol Chem 1997, 272:503-509.
60. Galibert M D, Carreira S, Goding C R. The Usf-1 transcription factor is a novel target for the stress- responsive p38 kinase and mediates UV-induced Tyrosinase expression. EMBO J 2001, 20:5022-5031.
61. Nylander K, Bourdon J C, Bray S E. Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response. J Pathol 2000, 190:39-46.
62. Khlgatian M K, Hadshiew I M, Asawanonda P. Tyrosinase gene expression is regulated by p53. J Invest Dermatol 2002, 118:126-132.
63. Schallreuter K U, Kothari S, Hasse S. In situ and in vitro evidence for DCoH/HNF-1 alpha transcription of tyrosinase in human skin melanocytes. Biochem Biophys Res Commun 2003, 301:610-616.
64. Hou L, Arnheiter H, Pavan W J. Interspecies difference in the regulation of melanocyte development by SOX10 and MITF. Proc Natl Acad Sci U S A 2006, 103:9081-9085.
65. Verastegui C, Bertolotto C, Bille K, Abbe P, Ortonne J P, Ballotti R. TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes. Mol Endocrinol 2000, 14:449-456.
66. Sturm R A, O'Sullivan B J, Box N F. Chromosomal structure of the human TYRP1 and TYRP2 loci and comparison of the tyrosinase-related protein gene family. Genomics 1995, 29:24-34.
67. Galibert M D, Yavuzer U, Dexter T J, Goding C R. Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter. J Biol Chem 1999, 274:26894-26900.
68. Carreira S, Dexter T J, Yavuzer U, Easty D J, Goding C R. Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter. Mol Cell Biol 1998, 18:5099-5108.
69. Hashimoto Y, Ito Y, Kato T, Motokawa T, Katagiri T, Itoh M. Expression profiles of melanogenesis-related genes and proteins in acquired melanocytic nevus. J Cutan Pathol 2006, 33:207-215.
70. Fang D, Hallman J, Sangha N. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma. Am J Pathol 2001, 158:2107-2115.
71. Fang D, Setaluri V. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1. Biochem Biophys Res Commun 1999, 256:657-663.
72. Eberle J, Garbe C, Wang N, Orfanos C E. Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro. Pigment Cell Res 1995, 8:307-313.
73. Fang D, Tsuji Y, Setaluri V. Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF. Nucleic Acids Res 2002, 30:3096-3106.
74. Vachtenheim J, Novotna H, Ghanem G. Transcriptional repression of the microphthalmia gene in melanoma cells correlates with the unresponsiveness of target genes to ectopic microphthalmia-associated transcription factor. J Invest Dermatol 2001, 117:1505-1511.
75. Yokoyama K, Yasumoto K, Suzuki H, Shibahara S. Cloning of the human DOPAchrome tautomerase/tyrosinase-related protein 2 gene and identification of two regulatory regions required for its pigment cell-specific expression. J Biol Chem 1994, 269:27080-27087.
76. Britsch S, Goerich D E, Riethmacher D. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev 2001, 15:66-78.
77. Potterf S B, Mollaaghababa R, Hou L. Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase. Dev Biol 2001, 237:245-257.
78. Jiao Z, Mollaaghababa R, Pavan W J, Antonellis A, Green E D, Hornyak T J. Direct interaction of Sox10 with the promoter of murine Dopachrome Tautomerase (Dct) and synergistic activation of Dct expression with Mitf. Pigment Cell Res 2004, 17:352-362.
79. Ludwig A, Rehberg S, Wegner M. Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors. FEBS Lett 2004, 556:236-244.
80. Stolt C C, Lommes P, Hillgartner S, Wegner M. The transcription factor Sox5 modulates Sox10 function during melanocyte development. Nucleic Acids Res 2008, 36:5427-5440.
81. Yasumoto K, Takeda K, Saito H, Watanabe K, Takahashi K, Shibahara S. Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J 2002, 21:2703-2714.
82. Murisier F, Beermann F. Genetics of pigment cells: lessons from the tyrosinase gene family. Histol Histopathol 2006, 21:567-578.
83. Fryer J P, Oetting W S, King R A. Identification and characterization of a DNase hypersensitive region of the human tyrosinase gene. Pigment Cell Res 2003, 16:679-684.
84. Regales L, Giraldo P, Garcia-Diaz A, Lavado A, Montoliu L. Identification and functional validation of a 5' upstream regulatory sequence in the human tyrosinase gene homologous to the locus control region of the mouse tyrosinase gene. Pigment Cell Res 2003, 16:685-692.
85. Ponnazhagan S, Hou L, Kwon B S. Structural organization of the human tyrosinase gene and sequence analysis and characterization of its promoter region. J Invest Dermatol 1994, 102:744-748.
86. Rousseau K, Kauser S, Pritchard L E. Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J 2007, 21:1844-1856.
87. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev 2000, 21:457-487.
88. Lazova R, Pawelek J M. Why do melanomas get so dark? Exp Dermatol 2009, 18:934-938.
89. Aoki H, Moro O. Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci 2002, 71:2171-2179.
90. Sato-Jin K, Nishimura E K, Akasaka E. Epistatic connections between microphthalmia-associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders. FASEB J 2008, 22:1155-1168.
91. Zbytek B, Wortsman J, Slominski A. Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol Endocrinol 2006, 20:2539-2547.
92. Cui R, Widlund H R, Feige E. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 2007, 128:853-864.
93. Slominski A, Tobin D J, Paus R. Does p53 regulate skin pigmentation by controlling proopiomelanocortin gene transcription? Pigment Cell Res 2007, 20:307-308.
94. Hida T, Wakamatsu K, Sviderskaya E V. Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway. Pigment Cell Melanoma Res 2009, 22:623-634.
95. Aberdam E, Bertolotto C, Sviderskaya E V. Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein. J Biol Chem 1998, 273:19560-19565.
96. Le Pape E, Passeron T, Giubellino A, Valencia J C, Wolber R, Hearing V J. Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r. Proc Natl Acad Sci USA 2009, 106:1802-1807.
97. Schallreuter K U, Hasse S, Rokos H. Cholesterol regulates melanogenesis in human epidermal melanocytes and melanoma cells. Exp Dermatol 2009, 18:680-688.
98. Berson J F, Harper D C, Tenza D, Raposo G, Marks M S. Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. Mol Biol Cell 2001, 12:3451-3464.
99. Du J, Miller A J, Widlund H R, Horstmann M A, Ramaswamy S, Fisher D E. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol 2003, 163:333-343.
100. Baxter L L, Pavan W J. Pmel17 expression is Mitf-dependent and reveals cranial melanoblast migration during murine development. Gene Expr Patterns 2003, 3:703-707.
101. Loftus S K, Antonellis A, Matera I. Gpnmb is a melanoblast-expressed, MITF-dependent gene. Pigment Cell Melanoma Res 2009, 22:99-110.
102. Ripoll V M, Meadows N A, Raggatt L J. Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB. Gene 2008, 413:32-41.
103. Hoashi T, Watabe H, Muller J, Yamaguchi Y, Vieira W D, Hearing V J. MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes. J Biol Chem 2005, 280:14006-14016.
104. Bassi M T, Schiaffino M V, Renieri A. Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome. Nat Genet 1995, 10:13-19.
105. Vetrini F, Auricchio A, Du J. The microphthalmia transcription factor (Mitf) controls expression of the ocular albinism type 1 gene: link between melanin synthesis and melanosome biogenesis. Mol Cell Biol 2004, 24:6550-6559.
106. Newton J M, Cohen-Barak O, Hagiwara N. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4. Am J Hum Genet 2001, 69:981-988.
107. Puri N, Gardner J M, Brilliant M H. Aberrant pH of melanosomes in pink-eyed dilution (p) mutant melanocytes. J Invest Dermatol 2000, 115:607-613.
108. Costin G E, Valencia J C, Vieira W D, Lamoreux M L, Hearing V J. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4. J Cell Sci 2003, 116:3203-3212.
109. Du J, Fisher D E. Identification of Aim-1 as the underwhite mouse mutant and its transcriptional regulation by MITF. J Biol Chem 2002, 277:402-406.
110. Duncan L M, Deeds J, Hunter J. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res 1998, 58:1515-1520.
111. McNeill M S, Paulsen J, Bonde G, Burnight E, Hsu M Y, Cornell R A. Cell death of melanophores in zebrafish trpm7 mutant embryos depends on melanin synthesis. J Invest Dermatol 2007, 127:2020-2030.
112. Miller A J, Du J, Rowan S, Hershey C L, Widlund H R, Fisher D E. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res 2004, 64:509-516.
113. Zhiqi S, Soltani M H, Bhat K M. Human melastatin 1 (TRPM1) is regulated by MITF and produces multiple polypeptide isoforms in melanocytes and melanoma. Melanoma Res 2004, 14:509-516.
114. Aspengren S, Hedberg D, Skold H N, Wallin M. New insights into melanosome transport in vertebrate pigment cells. Int Rev Cell Mol Biol 2009, 272:245-302.
115. Fukuda M, Kuroda T S, Mikoshiba K. Slac2-a/melanophilin, the missing link between Rab27 and myosin Va: implications of a tripartite protein complex for melanosome transport. J Biol Chem 2002, 277:12432-12436.
116. Matesic L E, Yip R, Reuss A E. Mutations in Mlph, encoding a member of the Rab effector family, cause the melanosome transport defects observed in leaden mice. Proc Natl Acad Sci U S A 2001, 98:10238-10243.
117. Chiaverini C, Beuret L, Flori E. Microphthalmia-associated transcription factor regulates RAB27A gene expression and controls melanosome transport. J Biol Chem 2008, 283:12635-12642.
118. Kawasaki A, Kumasaka M, Satoh A. Mitf contributes to melanosome distribution and melanophore dendricity. Pigment Cell Melanoma Res 2008, 21:56-62.
119. Gomez P F, Luo D, Hirosaki K. Identification of rab7 as a melanosome-associated protein involved in the intracellular transport of tyrosinase-related protein 1. J Invest Dermatol 2001, 117:81-90.
120. Kawakami A, Sakane F, Imai S. Rab7 regulates maturation of melanosomal matrix protein gp100/Pmel17/Silv. J Invest Dermatol 2008, 128:143-150.
121. Palmisano I, Bagnato P, Palmigiano A. The ocular albinism type 1 protein, an intracellular G protein-coupled receptor, regulates melanosome transport in pigment cells. Hum Mol Genet 2008, 17:3487-3501.
122. Dell'Angelica E C. The building BLOC(k)s of lysosomes and related organelles. Curr Opin Cell Biol 2004, 16:458-464.
123. Goodman R H, Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev 2000, 14:1553-1577.
124. De La Serna I, Ohkawa Y, Higashi C. The microphthalmia-associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes. J Biol Chem 2006, 281:20233-20241.
125. Sestakova B, Vachtenheim J. Distinct co-regulation of endogenous versus transfected MITF-dependent tyrosinase promoter. Folia Biol (Praha) 2006, 52:161-166.
126. Gaggioli C, Busca R, Abbe P, Ortonne J P, Ballotti R. Microphthalmia-associated transcription factor (MITF) is required but is not sufficient to induce the expression of melanogenic genes. Pigment Cell Res 2003, 16:374-382.
127. Schepsky A, Bruser K, Gunnarsson G J. The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression. Mol Cell Biol 2006, 26:8914-8927.
128. Yavuzer U, Keenan E, Lowings P, Vachtenheim J, Currie G, Goding C R. The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte- specific transcription. Oncogene 1995, 10:123-134.
129. Tonks I D, Hacker E, Irwin N. Melanocytes in conditional Rb-/- mice are normal in vivo but exhibit proliferation and pigmentation defects in vitro. Pigment Cell Res 2005, 18:252-264.
130. Butterfield L H, Stoll T C, Lau R, Economou J S. Cloning and analysis of MART-1/Melan-A human melanoma antigen promoter regions. Gene 1997, 191:129-134.
131. Tolmachova T, Ramalho J S, Anant J S, Schultz R A, Huxley C M, Seabra M C. Cloning, mapping and characterization of the human RAB27A gene. Gene 1999, 239:109-116.
132. Gillbro J M, Marles L K, Hibberts N A, Schallreuter K U. Autocrine catecholamine biosynthesis and the β2-adrenoceptor signal promote pigmentation in human epidermal melanocytes. J Invest Dermatol 2004, 123:346-353.
133. Kingo K, Aunin E, Karelson M. Gene expression analysis of melanocortin system in vitiligo. J Dermatol Sci 2007, 48:113-122.